176 related articles for article (PubMed ID: 38136993)
21. Association between PARK16 gene polymorphisms and susceptibility of Parkinson's disease in a Chinese population.
Xia H; Luo Q; Li XX; Yang XL
Genet Mol Res; 2015 Apr; 14(2):2978-85. PubMed ID: 25966061
[TBL] [Abstract][Full Text] [Related]
22. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
23. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
24. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
[TBL] [Abstract][Full Text] [Related]
25. Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease.
Pang S; Chen D; Zhang A; Qin X; Yan B
Neurosci Lett; 2012 Sep; 526(1):63-7. PubMed ID: 22867958
[TBL] [Abstract][Full Text] [Related]
26. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease.
Chen D; Pang S; Feng X; Huang W; Hawley RG; Yan B
Neurosci Lett; 2013 Feb; 534():193-8. PubMed ID: 23295909
[TBL] [Abstract][Full Text] [Related]
29. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
30. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
31. Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians.
Punia S; Das M; Behari M; Mishra BK; Sahani AK; Govindappa ST; Jayaram S; Muthane UB; K TB; Juyal RC
Pharmacogenet Genomics; 2010 Jul; 20(7):435-41. PubMed ID: 20498626
[TBL] [Abstract][Full Text] [Related]
32. Gene Panel Sequencing Analysis Revealed a Strong Contribution of Rare Coding Variants to the Risk of Parkinson's Disease in Sporadic Moroccan Patients.
Smaili I; Tibar H; Rahmani M; Machkour N; Razine R; Darai HN; Bouslam N; Benomar A; Regragui W; Bouhouche A
J Mol Neurosci; 2023 Jun; 73(6):391-402. PubMed ID: 37256495
[TBL] [Abstract][Full Text] [Related]
33. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease.
Patra B; Parsian AJ; Racette BA; Zhao JH; Perlmutter JS; Parsian A
Parkinsonism Relat Disord; 2009 Mar; 15(3):175-80. PubMed ID: 18752982
[TBL] [Abstract][Full Text] [Related]
34. Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson's disease.
Zhao N; Xiao J; Zheng Z; Fei G; Zhang F; Jin L; Zhong C
Neurosci Bull; 2015 Apr; 31(2):245-56. PubMed ID: 25758665
[TBL] [Abstract][Full Text] [Related]
35. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease.
Soto-Beasley AI; Walton RL; Valentino RR; Hook PW; Labbé C; Heckman MG; Johnson PW; Goff LA; Uitti RJ; McLean PJ; Springer W; McCallion AS; Wszolek ZK; Ross OA
Parkinsonism Relat Disord; 2020 Sep; 78():138-144. PubMed ID: 32829096
[TBL] [Abstract][Full Text] [Related]
36. Association of AQP4 single nucleotide polymorphisms (rs335929 and rs2075575) with Parkinson's disease: A case-control study.
Sun X; Tian Q; Yang Z; Liu Y; Li C; Hou B; Xie A
Neurosci Lett; 2023 Feb; 797():137062. PubMed ID: 36626962
[TBL] [Abstract][Full Text] [Related]
37. Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in Italy.
Albani D; Vittori A; Batelli S; Polito L; De Mauro S; Galimberti D; Scarpini E; Lovati C; Mariani C; Forloni G
Eur Neurol; 2009; 62(2):120-3. PubMed ID: 19521089
[TBL] [Abstract][Full Text] [Related]
38. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
Ferrari R; Wang Y; Vandrovcova J; Guelfi S; Witeolar A; Karch CM; Schork AJ; Fan CC; Brewer JB; ; ; ; Momeni P; Schellenberg GD; Dillon WP; Sugrue LP; Hess CP; Yokoyama JS; Bonham LW; Rabinovici GD; Miller BL; Andreassen OA; Dale AM; Hardy J; Desikan RS
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):152-164. PubMed ID: 27899424
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease.
De Marco EV; Tarantino P; Rocca FE; Provenzano G; Civitelli D; De Luca V; Annesi F; Carrideo S; Cirò Candiano IC; Romeo N; Nicoletti G; Marconi R; Novellino F; Morelli M; Quattrone A; Annesi G
Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):403-7. PubMed ID: 17918232
[TBL] [Abstract][Full Text] [Related]
40. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
